Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

INTRODUCTION: Prolonged glucocorticoid use may increase the risk of adverse safety outcomes, including cardiovascular events. The European League Against Rheumatism and the Canadian Rheumatology Association advise tapering glucocorticoid dose as rapidly as clinically feasible. There is a paucity of...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:RMD Open
Main Authors: Alten, Rieke, Nüßlein, Hubert, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Mélanie, Poncet, Coralie, Rauch, Christiane, Elbez, Yedid, Le Bars, Manuela
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2016
Fag:
Rheumatoid Arthritis
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762207/
https://ncbi.nlm.nih.gov/pubmed/26925253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000228
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker